May 10 |
Q1 2024 Xeris Biopharma Holdings Inc Earnings Call
|
May 9 |
Xeris Biopharma Holdings, Inc. (XERS) Q1 2024 Earnings Call Transcript
|
May 9 |
Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
|
May 9 |
Xeris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.02, revenue of $40.64M misses by $1.17M
|
May 9 |
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events
|
May 8 |
Xeris Pharmaceuticals Q1 2024 Earnings Preview
|
May 6 |
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
|
May 2 |
Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock
|
May 2 |
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
|
Apr 17 |
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
|